Preview

Научно-практическая ревматология

Расширенный поиск

СИСТЕМНАЯ КРАСНАЯ ВОЛЧАНКА И ВИРУСНЫЕ ИНФЕКЦИИ (Обзор литературы)

https://doi.org/10.14412/1995-4484-2000-1447

Список литературы

1. <div><p>Егорова О.Н., Балабанова P.M., Чувиров Г.Н. Значение антител к семейству Herpesviridae при ревматических заболеваниях. Тер. арх., 1998, 5, 70, 41.</p><p>Ревматические болезни. Руководство для врачей под ред. Насоновой В.А. и Бунчука Н.В. М., Медицина, 1997.</p><p>Abu-Shakra М., El-Sana S., Margalith М., Sikuler Е., Neumann L., Buskila D. Hepatitis В and С viruses serology in patients with SLE. Lupus, 1997, 6, 6, 543-544.</p><p>Banki K, Ablonczy E, Nakamura M, Perl A. Effect of p40tax activator of Human T Cell lympholropic virus type I on expression of auloantigens. AIDS Res. Hum Retrov., 1994, 10, 303-308.</p><p>Banno S., Matsumoto Y., Sugiura Y., Ueda R. Human parvovirus B19 infection mimicking systemic lupus erythematosus: case report. Ryumachi, 1997, 37, 4, 581-586.</p><p>Bottazzo G.F., Pujol-Borell R., Hanafusa Т., Feldmann M. Role of abberant HLA-DR expression and atigen presentation in induction of endocrine autoimmunity. Lancet, 1983, 2, 1115-1119.</p><p>Caramaschi P., Zeminian S., Carletto A., Bi- asi D., Marino A., Bambara L.M. Parvovirus В19 infection and rheumatic diseases. Rev. Rhum. Engl. Ed., 1996, 63, 11, 846-853.</p><p>Chang B.G., Markowitz G.S., Seshan S.V., Seigle R.L., D’Agati V.D. Renal manifestations of concurrent systemic lupus erythematosus and HIV infection Am J. Kidney Dis, 1999, 33, 3, 441-449.</p><p>Chapman A.J., Farell H.E., Thomas J.A., Papdimitiou J.M., Garlepp M.J., Scalzo A.A., Shellam G.R. A murine cytomegalovirus-neutralizing monoclonal antibody exhibits autoreactivity and induces tissue damage in vivo. Immunology, 1994, 81, 435-43.</p><p>Chung A.B., Fas N. Successful acyclovir treatment of herpes simplex type 2 hepatitis in a patient with systemic lupus erythematosus: a case report and meta analysis. Am. J. Med. Sci., 1998, 316, 6, 404-407.</p><p>Cooke A, Lydyard PM, Roitt IM. Mechanisms of autoimmunity: a role of cross-reactive anti-idiotypes. Immunol. Today, 1983, 4, 170-175.</p><p>De la Cruz Morron I., Alfageme Michavila I., Munoz Lucena F., Ramos P., Rojas J.L., Garcria Polo C. Pneumonia due to varicella zoster virus in adults: a review of 13 cases. Arch. Bronconeumol, 1999, 35, 7, 357-359.</p><p>Deas J.E., Liu L.G., Thompson J.J., Sander D.M., Soble S.S., Garry R.F., Gallaher W.R. Reactivity of sera from systemic lupus erythematosus and SjEogren’s syndrome patients with peptides derived from human immunodeficiency virus p24 capsid antigen. Clin. Diagn. Lab. Immunol., 1998, 5, 2, 181-185.</p><p>Dibner R.M., M.D. &amp; Colman, Carol. The Lupus Handbook for Women. NY: Simon &amp; Schuster, 1994.</p><p>Dror Y., Blachar Y., Cohen P., Livni N., Rosenmann E., Ashkenazi A. Systemic lupus erythematosus associated with acute Epstein- Barr virus infection. Am J Kidney Dis., 1998, 32, 5, 825-828.</p><p>Etienne A., Harms M. Cutaneous manifestations of parvovirus В19 infection. Presse Med, 1996, 25, 25, 1162-1165.</p><p>Faghiri Z., Wilson W.A., Taheri F., Barton E. N., Morgan O.S., Gharavi A.E. Antibodies to cardiolipin and beta2-glycoprotein-l in HTLV-1-associated myelopathy/tropical spastic paraparesis. Lupus, 1999, 8, 3, 210-214.</p><p>Fox R.A., Isenberg D.A. Human immunodeficiency virus infection in systemic lupus erythematosus. Arthr. Rheum., 1997, 40, 6, 1168-1172.</p><p>Fredriksen K., Osei A., Sundsfjord A., Traa- vik Т., Rekvig O.P. On the biological origin of anti dsDNA antibodies: systemic lupus erytha- ematosus related anti-dsDNA antibodies are induced by polyomavirus BK in lupu-prone (NZBxNZW) FI hybrids, but not in normal mice. Eur. J. Immunol., 1994, 24, 66-70.</p><p>Fukui Т., Sugita K., Ichikawa H., Negishi A., Kasai H., Tsukagoshi H. Human T-lympho- tropic virus type 1 associated myelopathy and myasthenia gravis: a possible association? Eur. Neurol., 1994, 34, 158-161.</p><p>Giordano P., Galli М., Del Vecchio G.C., Al- lomare М., Norbis F., Ruggeri L., Petronelli М., de Mattia D. Lupus anticoagulant, anti- cardiolipin antibodies and hepatitis С virus infection in thalassaemia. Br. J. Haematol., 1998, 102, 4, 903-906.</p><p>Griffiths D.J., Cooke S.P., Hervre C., Rigby S.P., Mallon E., Hajeer A., Lock М., Emery V., Taylor P., Pantelidis P., Bunker СВ., du Bois R., Weiss R.A., Venables P.J. Detection of human retrovirus 5 in patients with arthritis and systemic lupus erythematosus. Arthr. Rheum., 1999, 42, 3, 448-454.</p><p>Harley J.B., James J.A. Epstein-Barr virus infection may be an environmental risk factor for systemic lupus erythematosus in children and teenagers [letter] Arthr. Rheum., 1999, 42, 8, 1782-1783.</p><p>Hayashi Т., Lee S., Ogasawara H., Sekigawa I., Iida N., Tomino Y., Hashimoto H., Hirose S. Exacerbation of systemic lupus erythematosus related to cytomegalovirus infection. Lupus, 1998, 7, 8, 561-564.</p><p>Hemmerich P., Neu E., Macht М., Peter H.H., Krawinkel U., von Mikecz A. Correlation between chlamydial infection and autoimmune response: molecular mimicry between RNA polymerase major sigma subunit from Chlamydia trachomatis and human L7. Eur. J. Immunol., 1998, 28, 11, 3857-3866.</p><p>Incaprera М., Rindi L„ Bazzichi A., Garzelli C. Potential role of the Epstein-Barr virus in systemic lupus erythematosus autoimmunity. Clin. Exp. Rheumatol., 1998, 16, 3, 289-294.</p><p>James J.A., Kaufman K.M., Farris A.D., Tay- lor-Albert E., Lehman T.J., Harley J.B. An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus. J. Clin. Invest., 1997, 100, 12, 3019-3026.</p><p>KhozinskyV.V., Semenov B.F. In vivo inhibition by intact mouse serum of the activity of the flavivirus-induced T-suppressors of autoreactive T-lymphocytes. Acta-Virol-Praha, 1984, 28, 212-217.</p><p>Kishimoto T. Interleukin-6 and its receptor in autoimmunity. J. Autoimm., 1992, 5, suppl A, 123-132.</p><p>Kohn L.D., Kosugi S., Ban Т., Saji М., Ikuya- ma S., Hidaka A., Shimura H., Akamizu Т., Tahara K. Molecular basis for the autoreactivity against thyroid stimulating hormone receptor. Int. Rev. Immunol., 1992, 9, 135-165.</p><p>Kowal C., Weinstein A., Diamond B. Molecular mimicry between bacterial and self antigen in a patient with systemic lupus erythematosus. Eur. J. Immunol., 1999, 29, 6, 19011911.</p><p>Kowdley K.V., Subler D.E., Scheffel J., Moore B. , Smith H. Hepatitis С virus antibodies in systemic lupus erythematosus. J. Clin. Gastroenterol, 1997, 25, 2, 437-439.</p><p>Kudva Y.C., Peterson L.S., Holley K.E., Wright A.J., Hunder G.G. SLE nephropathy in a patient with HIV infection: case report and review of the literature. J. Rheumatol., 1996, 23, 10, 1811-1815.</p><p>Lach-Trifilieff E., Marfurt J., Schwarz S., Sad- allah S., Schifferli J.A. Complement receptor 1 (CD35) on human reticulocytes: normal expression in systemic lupus erythematosus and HIV-infected patients. J. Immunol., 1999, 162, 12, 7549-7554.</p><p>Langgartner J., Andus Т., Hemauer A., Scholmerich J., Lang B. Imitation of an acute exacerbation of established systemic lupus erythematosus caused by parvovirus B19 infection. Dtsch. Med. Wochenschr., 1999, 124, 28-29, 859-862.</p><p>Lasch J.A., Klussmann J.P., Krueger G.R. Human herpesviruses 6 and 7. Basic principles and possible significance for dermatology. Hautarzt, 1996, 47, 5, 341-350.</p><p>Lipka K., Tebbe B., Finckh U., Rolfs A. Absence of human T-lymphotrophic virus type I in patients with systemic lupus erythematosus. Clin. Exp. Dermatol., 1996, 21, 1, 38-42.</p><p>Lu C.L., Tsai S.T., Chan C.Y., Hwang S.J., Tsai C. Y., Wu J.C., Lu R.H., Lin B.C., Lee S.D. Hepatitis В infection and changes in interferon-alpha and -gamma production in patients with systemic lupus erythematosus in Taiwan. J. Gastroenterol. Hepatol., 1997, 12, 4, 272276.</p><p>Maisch B., Trostel-Soder R., Stechmesser E., Berg P.A., Kochseik K.K. Diagnostic relevance of humoral and cell mediated immune reactions in patients with acute viral myocarditis. Clin. Exp. Immunol., 1982, 48, 533-545.</p><p>Martrinez Aguilar N.E., Guido Bayardo R., Vargas Camano M.E., Compan Gonralez D., Ramrirez Ojeda H. Clinical polymorphism in Epstein-Barr virus infection. Rev. Alerg. Mex., 1997, 44, 2, 45-50.</p><p>Maudsley D.J., Pound J.D. Modulation of MHC antigen expression by viruses and oncogenes. Immunol. Today, 1991, 12, 429-431.</p><p>Mishiro S., Hoshi Y., Takeda K. Non A, non В hepatitis specific antibodies directed at a host- derived epitope: implication for an autoimmune process. Lancet, 1990, 11, 1400-1403.</p><p>Mittleman B.B., Morse H.C., Payne S.М., Shearer G.M., Mozes E. Amelioration of experimental systemic lupus erythematosus (SLE) by retrovirus infection. J. Clin. Immunol., 1996, 16, 4, 230-236.</p><p>Miura Т., Tanaka H., Makino Y., Okamo- to K., Iida Т., Komura K., Fukawa E., Hira- no F., Makino I. Human T cell leukemia virus type I-associated myelopathy in a patient with systemic lupus erythematosus. Intern. Med. 1999, 38, 6, 512-515.</p><p>Mokhtarian F., Shi Y., Zhu P.F., Grob D. Immune responses, and Autoimmune outcome, during virus infection of the central nervous system. Cell. Immunol., 1994, 157, 195-210.</p><p>Moore T.L., Bandlamudi R., Alam S.М., Nesher G. Parvovirus infection mimicking systemic lupus erythematosus in a pediatric population. Semin. Arthr. Rheum., 1999, 28, 5, 314-318.</p><p>Mountz J.D., Talal N. Retroviruses, apopto- sis and autogenes. Immunol. Today, 1993, 14, 532-536.</p><p>Munoz-Rodrriguez F.J., Tassies D., Font J., Reverter J.C., Cervera R., Sranchez-Tapias J.M., Mazzara R., Ordinas A., Ingelmo M. Prevalence of hepatitis С virus infection in patients with antiphospholipid syndrome. J. Hepatol., 1999, 30, 5, 770-773.</p><p>Muraoka H., Tokeshi S., Abe H., Miyahara Y„ Uchimura Y„ Noguchi S., Sata М., Tani- kawa K. Two cases of adult varicella accompanied by hepatic dysfunction. Kansenshog- aku Zasshi, 1998, 72, 4, 418-423.</p><p>Naides S.J. Rheumatic manifestations of parvovirus B19 infection. Rheum. Dis. Clin. North. Am., 1998, 24, 2, 375-401.</p><p>Nesher G., Moore L. T. Human Parvovirus Infection. Infec. Med. 1997, 14, 8, 637-638, 640-642.</p><p>Rabausch-Starz I., Schwaiger A., Grune- wald K, Muller-Hermelink HK, Neu N. Persistence of virus and viral genome in myocardium after coxsackievirus B3 induced murine myocarditis. Clin. Exp. Immunol., 1994, 96, 69-74.</p><p>Rider J.R., Oilier W.E., Lock R.J., Brookes S.T., Pamphilon D.H. Human cytomegalovirus infection and systemic lupus erythematosus. Clin. Exp. Rheumatol., 1997, 15, 4, 405940.</p><p>Rioux J.D., Rauch J., Silvestri L., Newkirk M.M. A human rheumatoid factor C304 shares VH and VL gene usage with antibodies specific for ubiquitous human viral pathogens. Scand. J. Immunol., 1994, 40, 350-354.</p><p>Rose N.R., Herskowitz A., Neumann D.A., Neu N. Autoimmune myocarditis: a paradigm of post-infection autoimmune disease. Immunol. Today, 1988, 9, 117-120.</p><p>Rosen A., Casciola-Rosen L. Autoantigens as substrates for apoptotic proteases: implications for the pathogenesis of systemic autoimmune disease. Cell Death Differ, 1999, 6, 1,612.</p><p>Sandri-Goldin R.M., Hibbard M.K. The herpes simplex virus type 1 regulatory protein ICP27 coimmunoprecipitates with anti-Sm antiserum, and the С terminus appears to be required for this interaction. J. Virol, 1996, 70, 1, 108-118.</p><p>Schattner A., Rager-Zisman B., Virus-induced autoimmunity. Rev. Infect. Dis, 1990, 12, 205218.</p><p>Schattner A. Interferons and autoimmunity. Am. J. Med. Sci., 1988, 295, 532-544.</p><p>Sekigawa I., Kaneko H., Hishikawa Т., Hash- imoto H., Hirose S., Kaneko Y., Maruyama N. HIV infection and SLE: their pathogenic relationship. Clin. Exp. Rheumatol., 1998, 16, 2, 175-180.</p><p>Setoyama М., Mizoguchi S., Eizuru Y. Human T-cell lymphotropic virus type I infects eccrine sweat gland epithelia. Int. J. Cancer, 1999, 80, 5, 652-655.</p><p>Sraer J.D., Peraldie M.N. Human immunodeficiency virus and acute renal insufficiency. Bull. Acad. Natl. Med., 1997, 181,9, 1763-1779.</p><p>Strephan J.L., Galambrun C. Lymphohistio- cyte activation syndromes associated with Epstein-Barr vims. Pathol. Biol. (Paris), 1997, 45, 2, 131-136.</p><p>Sugimoto H., Hashimoto N., Suzuki S., Gejyo F. The clinical significance of the measurement of serum soluble interleukin-2 receptors in various diseases. Rinsho Byori, 1996, 44, 2, 176-182.</p><p>Toulon P. Hemostasis and human immunodeficiency virus (HIV) infection. Ann Biol. Clin. (Paris), 1998, 56, 2, 153-160.</p><p>Trapani S., Ermini М., Falcini F. Human parvovirus B19 infection: its relationship with systemic lupus erythematosus. Semin. Arthr. Rheum., 1999, 28, 5, 319-325.</p><p>Vanguri P., Farber J.M. IFN and Virus-induc- ible expression of an Immediate early gene, crg-2/IP-10, and a delayed gene I-А, in Astrocytes and Microglia. J. Immunol., 1994, 152, 1411-1418.</p><p>Wong K.F., Chan J.K., Lo E.S., Wong C.S. A study of the possible etiologic association of Epstein-Barr virus with reactive hemophago- cytic syndrome in Hong Kong Chinese. Hum. Pathol., 1996, 27, 11, 1239-1242.</p></div><br />


Рецензия

Для цитирования:


Goryachev D.V., Егорова О.Н., Балабанова Р.М. СИСТЕМНАЯ КРАСНАЯ ВОЛЧАНКА И ВИРУСНЫЕ ИНФЕКЦИИ (Обзор литературы). Научно-практическая ревматология. 2000;38(3):45-54. https://doi.org/10.14412/1995-4484-2000-1447

For citation:


Goryachev D.V., Egorova O.N., Balabanova R.M. SISTEMNAYa KRASNAYa VOLChANKA I VIRUSNYE INFEKTsII (Obzor literatury). Rheumatology Science and Practice. 2000;38(3):45-54. (In Russ.) https://doi.org/10.14412/1995-4484-2000-1447

Просмотров: 869


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 1995-4484 (Print)
ISSN 1995-4492 (Online)